Catalent, Inc. to Present at the 37th Annual J.P. Morgan Health Care Conference
SOMERSET, N.J.--(BUSINESS WIRE)--Dec 19, 2018--Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that John Chiminski, Chairman & Chief Executive Officer, will present at the 37 th Annual J.P. Morgan Health Care Conference at 10:30 a.m. PT on Monday, January 7, 2019 in San Francisco, CA.
A live webcast of the presentations will be accessible through the Company’s website at http://investor.catalent.com and will be available for replay following the event.
About Catalent, Inc.
Catalent is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products. With over 80 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable clinical and commercial product supply. Catalent employs over 11,000 people, including over 1,800 scientists, at more than 30 facilities across 5 continents and in fiscal 2018 generated approximately $2.5 billion in annual revenue. Catalent is headquartered in Somerset, N.J. For more information visit www.catalent.com.
More products. Better treatments. Reliably supplied.™
View source version on businesswire.com:https://www.businesswire.com/news/home/20181219005608/en/
CONTACT: Investor Contact:
KEYWORD: UNITED STATES NORTH AMERICA NEW JERSEY
INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY PHARMACEUTICAL
SOURCE: Catalent, Inc.
Copyright Business Wire 2018.
PUB: 12/19/2018 04:15 PM/DISC: 12/19/2018 04:15 PM